Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
14/04/2026 18:40
April 14 (Reuters) - OSE Immunotherapeutics SA OSE.PA: OSE IMMUNOTHERAPEUTICS SA: APPOINTING THOMAS GIDOIN AS DEPUTY CHIEF EXECUTIVE OFFICER Source text: ID:nGNX4HhGjH Further company coverage: OSE.PA ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO